NYSE · BRO

Brown & Brown, Inc.

$72.92 +$5.26 (+7.77%) 1D Market open
Session Pulse Regular session 1 mentions on Mon 1 SEC filing since Mon close 8-K its sector ranked 4/11 this week Full pulse →

Key Metrics

$22.93B
Market cap
19.96×
P/E · TTM
$6.40B
Revenue · TTM
$1.15B
Net income
EPS · TTM $4.03
Dividend yield 0.9%
Free cash flow $1.43B
Beta · 1Y -0.29
EBITDA · TTM $1.54B
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    A material event was filed (Form 8-K).

    8-K - BROWN & BROWN, INC. (0000079282) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 13
    From its Feb 4 high, the share price fell 27%.

    Peak close $74.03 on Feb 4; trough close $54.38 on May 13. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -27%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$22.93B
Enterprise value$29.75B
Shares outstanding338.9M
52-wk range$53.81 – $98.30
Avg volume · 20D1.8M
Net cash −$6.82B
Book value / share$44.26
IndustryInsurance Agents, Brokers & Service
ExchangeNYSE
About Brown & Brown, Inc.
IPO dateFeb 27, 1981
Employees22888

Brown & Brown Inc is a diversified insurance agency, wholesale brokerage, insurance programs, and service. The company's business is divided into two reportable segments: (i) the Retail segment, and (ii) the Specialty Distribution segment.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E19.96
P/S3.58
P/FCF16.07
EV/EBITDA19.34
EV/Sales4.65
Graham №$63.36

Profitability

Gross
Operating 23.1%
Net 18.0%
FCF 22.3%
ROE / ROIC 12.1% · 6.0%

Financial Health

Current ratio1.02
Quick ratio
Debt / equity0.62
Debt / EBITDA 5.09
Net cash −$6.82B
Working capital$139.00M

Cash Flow · TTM

Operating CF $1.50B
Capex −$72.00M
Free cash flow $1.43B
Buybacks
Dividends paid $207.00M
Shareholder yield 0.9%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$63.36 vs $69.70
Trades 1.1× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings